Internal Medicine, Nephrology · Cincinnati, OH
NPI
1023138401
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4750 E Galbraith Rd, Suite 103
Cincinnati, OH, 45236
Phone (513) 984-3500
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
5,735 services
Medicare patients, 2024
1,196
Average age 76
Drug cost, 2024
$975K
9,137 prescriptions
Company payments, 2025
$15K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arshdeep Tindni was code 99214 (office e&m - established), 1,486 times for 753 patients. In total Arshdeep Tindni billed 5,735 services in 24 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,486 | 753 | $83.46 | $124K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 991 | 667 | $12.29 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 837 | 232 | $57.82 | $48K |
| 99233 Hospital E&M - Subsequent | Facility | 816 | 249 | $88.36 | $72K |
| 99223 Hospital E&M - Initial | Facility | 350 | 269 | $126.80 | $44K |
| 90966 ESRD Related Services (not dialysis) | Office | 200 | 43 | $217.75 | $44K |
| 99213 Office E&M - Established | Office | 181 | 162 | $57.82 | $10K |
| 90960 ESRD Related Services (not dialysis) | Office | 149 | 35 | $263.03 | $39K |
| 90945 Peritoneal Dialysis | Facility | 133 | 18 | $63.75 | $8,479 |
| 90961 ESRD Related Services (not dialysis) | Office | 121 | 41 | $215.86 | $26K |
| 99204 Office E&M - New | Office | 100 | 100 | $107.41 | $11K |
| 99215 Office E&M - Established | Office | 84 | 44 | $113.47 | $9,531 |
| 90935 Hemodialysis | Facility | 63 | 42 | $52.48 | $3,306 |
| 99222 Hospital E&M - Initial | Facility | 62 | 52 | $98.19 | $6,088 |
| 90962 ESRD Related Services (not dialysis) | Office | 48 | 21 | $151.55 | $7,274 |
By year: 2022 $446K for 4,385 services; 2023 $514K for 5,003 services; 2024 $485K for 5,735 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arshdeep Tindni prescribed most often to Medicare patients was Amlodipine Besylate, with 802 prescriptions and refills. In total Arshdeep Tindni wrote 9,137 Medicare prescriptions that cost $975K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 802 | 2,126 | 260 | $3,933 |
| Losartan Potassium Generic | 792 | 2,080 | 259 | $5,819 |
| Furosemide Generic | 719 | 1,665 | 246 | $2,998 |
| Spironolactone Generic | 658 | 1,403 | 171 | $8,584 |
| Torsemide Generic | 430 | 893 | 137 | $11K |
| Hydralazine Hcl Generic | 410 | 827 | 119 | $5,331 |
| Jardiance Empagliflozin | 363 | 778 | 115 | $401K |
| Lisinopril Generic | 302 | 822 | 97 | $1,607 |
| Valsartan Generic | 258 | 632 | 87 | $6,834 |
| Allopurinol Generic | 225 | 574 | 68 | $1,847 |
| Carvedilol Generic | 200 | 463 | 58 | $1,763 |
| Calcitriol Generic | 196 | 392 | 56 | $2,427 |
| Doxazosin Mesylate Generic | 185 | 436 | 52 | $3,046 |
| Nifedipine Er Nifedipine | 172 | 363 | 51 | $4,978 |
| Metoprolol Succinate Generic | 158 | 380 | 48 | $1,613 |
Brand drugs: - claims; generic drugs: 8,193 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arshdeep Tindni $15K ($15K in general payments such as food, travel and fees) from 11 companies. The largest payer was Akebia Therapeutics Inc with $14K.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 22 | $14K |
| Mallinckrodt Hospital Products Inc. | 3 | $208 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $96.05 |
| Outset Medical Inc OM | 1 | $58.57 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.98 |
| Ardelyx, Inc. ARDX | 2 | $40.35 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $27.78 |
| Vifor Pharma, Inc. | 1 | $27.38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19.54 |
| Merck Sharp & Dohme LLC MRK | 1 | $19.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.